Show simple item record

dc.contributor.authorYiangou, Loukia
dc.contributor.authorGrandy, Rodrigo A
dc.contributor.authorMorell, Carola
dc.contributor.authorTomaz, Rute A
dc.contributor.authorOsnato, Anna
dc.contributor.authorKadiwala, Juned
dc.contributor.authorMuraro, Daniele
dc.contributor.authorGarcia-Bernardo, Jose
dc.contributor.authorNakanoh, Shota
dc.contributor.authorBernard, William
dc.contributor.authorOrtmann, Daniel
dc.contributor.authorMcCarthy, Davis J
dc.contributor.authorSimonic, Ingrid
dc.contributor.authorSinha, Sanjay
dc.contributor.authorVallier, Ludovic
dc.date.accessioned2019-01-08T00:31:04Z
dc.date.available2019-01-08T00:31:04Z
dc.date.issued2019-01-08
dc.identifier.issn2213-6711
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/287609
dc.description.abstractCell cycle progression and cell fate decisions are closely linked in human pluripotent stem cells (hPSCs). However, the study of these interplays at the molecular level remains challenging due to the lack of efficient methods allowing cell cycle synchronization of large quantities of cells. Here, we screened inhibitors of cell cycle progression and identified nocodazole as the most efficient small molecule to synchronize hPSCs in the G2/M phase. Following nocodazole treatment, hPSCs remain pluripotent, retain a normal karyotype and can successfully differentiate into the three germ layers and functional cell types. Moreover, genome-wide transcriptomic analyses on single cells synchronized for their cell cycle and differentiated toward the endoderm lineage validated our findings and showed that nocodazole treatment has no effect on gene expression during the differentiation process. Thus, our synchronization method provides a robust approach to study cell cycle mechanisms in hPSCs.
dc.description.sponsorshipThis work was supported by the Wellcome Trust PhD program (PSAG/048 to L.Y. and PSAG/051 to A.O.); the European Research Council advanced grant New-Chol (ERC: 741707 to L.V. and R.A.G.), the Cambridge University Hospitals National Institute for Health Research Biomedical Research Center (to L.V.); an NC3Rs grant (NC/N001540/1 to C.M.M.), an MRC UK-RPM II grant (to R.A.T.), a Grant-in-Aid for JSPS Research Fellow (16J08005 to S.N.), a BHF Senior Research Fellowship (FS/13/29/30024 to S.S.), the Cystic Fibrosis Foundation, the Cystic Fibrosis Trust, a core support grant from the Wellcome and Medical Research Council to the Wellcome – Medical Research Council Cambridge Stem Cell Institute (PSAG028) and a core support grant from the Wellcome Trust to the Wellcome Trust Sanger Institute (WT206194).
dc.format.mediumPrint-Electronic
dc.languageeng
dc.publisherElsevier BV
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectCell Line
dc.subjectEndoderm
dc.subjectHumans
dc.subjectNocodazole
dc.subjectCell Cycle
dc.subjectCell Differentiation
dc.subjectTubulin Modulators
dc.subjectTranscriptome
dc.subjectKaryotype
dc.subjectCellular Reprogramming Techniques
dc.subjectHuman Embryonic Stem Cells
dc.titleMethod to Synchronize Cell Cycle of Human Pluripotent Stem Cells without Affecting Their Fundamental Characteristics.
dc.typeArticle
prism.endingPage179
prism.issueIdentifier1
prism.publicationDate2019
prism.publicationNameStem Cell Reports
prism.startingPage165
prism.volume12
dc.identifier.doi10.17863/CAM.34921
dcterms.dateAccepted2018-11-29
rioxxterms.versionofrecord10.1016/j.stemcr.2018.11.020
rioxxterms.versionVoR
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2019-01
dc.contributor.orcidOsnato, Anna [0000-0001-5241-1512]
dc.contributor.orcidBernard, William [0000-0002-2622-5115]
dc.contributor.orcidSinha, Sanjay [0000-0001-5900-1209]
dc.contributor.orcidVallier, Ludovic [0000-0002-3848-2602]
dc.identifier.eissn2213-6711
rioxxterms.typeJournal Article/Review
pubs.funder-project-idEuropean Research Council (741707)
pubs.funder-project-idBritish Heart Foundation (None)
pubs.funder-project-idWellcome Trust (097922/B/11/Z)
pubs.funder-project-idMedical Research Council (MC_PC_12009)
pubs.funder-project-idNational Centre for the Replacement Refinement and Reduction of Animals in Research (NC/N001540/1)
pubs.funder-project-idNational Centre for the Replacement Refinement and Reduction of Animals in Research (NC/R001987/1)
pubs.funder-project-idBritish Heart Foundation (BHF-FS/18/46/33663)


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's licence is described as Attribution 4.0 International